{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:24:08Z","timestamp":1794349448533,"version":"4.9.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["23K06842"],"award-info":[{"award-number":["23K06842"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["22K08790"],"award-info":[{"award-number":["22K08790"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neures.2026.105135","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:06:47Z","timestamp":1791040007000},"page":"105135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Centrally administered SGLT2 inhibitor improves gut barrier function through the brain orexin, AMPK, dopamine D2 signaling and the vagal pathway in rats"],"prefix":"10.1016","volume":"232","author":[{"given":"Takuya","family":"Funayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Nozu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatomo","family":"Ishioh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Sumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Hatayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1810-007X","authenticated-orcid":false,"given":"Toshikatsu","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neures.2026.105135_bib1","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","article-title":"Leaky gut: mechanisms, measurement and clinical implications in humans","volume":"68","author":"Camilleri","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.neures.2026.105135_bib2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrd3180","article-title":"SGLT2 inhibition--a novel strategy for diabetes treatment","volume":"9","author":"Chao","year":"2010","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.neures.2026.105135_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s13300-010-0006-4","article-title":"Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members","volume":"1","author":"Chen","year":"2010","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.neures.2026.105135_bib4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/neup.12665","article-title":"Sodium\/glucose cotransporter 2 is expressed in choroid plexus epithelial cells and ependymal cells in human and mouse brains","volume":"40","author":"Chiba","year":"2020","journal-title":"Neuropathology"},{"key":"10.1016\/j.neures.2026.105135_bib5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neures.2026.105135_bib6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1460-9568.2009.07065.x","article-title":"The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system","volume":"31","author":"Espa\u00f1a","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neures.2026.105135_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148371","article-title":"Centrally administered GLP-1 analogue improves intestinal barrier function through the brain orexin and the vagal pathway in rats","volume":"1809","author":"Funayama","year":"2023","journal-title":"Brain Res."},{"key":"10.1016\/j.neures.2026.105135_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2025.138208","article-title":"Brain AMPK signaling improves intestinal barrier function through brain orexin and the vagal pathway in rats","volume":"854","author":"Funayama","year":"2025","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neures.2026.105135_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108116","article-title":"Ghrelin acts in the brain to block colonic hyperpermeability in response to lipopolysaccharide through the vagus nerve","volume":"173","author":"Ishioh","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neures.2026.105135_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113708","article-title":"Activation of central adenosine A2B receptors mediate brain ghrelin-induced improvement of intestinal barrier function through the vagus nerve in rats","volume":"341","author":"Ishioh","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neures.2026.105135_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116201","article-title":"Brain histamine improves colonic hyperpermeability through the basal forebrain cholinergic neurons, adenosine A2B receptors and vagus nerve in rats","volume":"224","author":"Ishioh","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neures.2026.105135_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2026.117946","article-title":"\u03b2-Hydroxybutyrate modulates intestinal barrier function and visceral sensitivity via a brain AMPK-orexin pathway recruiting histamine H1 receptors, basal forebrain cholinergic neurons, adenosine A2B receptors, and vagal output in rats","volume":"250","author":"Ishioh","year":"2026","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neures.2026.105135_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.coph.2018.08.011","article-title":"Mucosal permeability and mast cells as targets for functional gastrointestinal disorders","volume":"43","author":"Keita","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neures.2026.105135_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1538\/expanim.48.137","article-title":"Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium","volume":"48","author":"Kitajima","year":"1999","journal-title":"Exp. Anim."},{"key":"10.1016\/j.neures.2026.105135_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/00365529409090435","article-title":"Evans blue permeation of intestinal mucosa in the rat","volume":"29","author":"Lange","year":"1994","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.neures.2026.105135_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11897-024-00648-y","article-title":"Heart Failure: a Punch from the Gut","volume":"21","author":"Mahenthiran","year":"2024","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.neures.2026.105135_bib17","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neures.2026.105135_bib18","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2147\/DMSO.S258593","article-title":"Dapagliflozin Activates Neurons in the Central Nervous System and Regulates Cardiovascular Activity by Inhibiting SGLT-2 in Mice","volume":"13","author":"Nguyen","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.neures.2026.105135_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173565","article-title":"Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome","volume":"887","author":"Nozu","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neures.2026.105135_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2025.171394","article-title":"Irisin prevents visceral hypersensitivity and colonic hyperpermeability in a rat model of irritable bowel syndrome","volume":"188","author":"Nozu","year":"2025","journal-title":"Peptides"},{"key":"10.1016\/j.neures.2026.105135_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.70389","article-title":"L-Carnitine Improves Visceral Hypersensitivity and Colonic Hyperpermeability in a Rat Model of Irritable Bowel Syndrome","volume":"38","author":"Nozu","year":"2026","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.neures.2026.105135_bib22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/jgh.13808","article-title":"Glucagon-like peptide-1 analog, liraglutide, improves visceral sensation and gut permeability in rats","volume":"33","author":"Nozu","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.neures.2026.105135_bib23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejphar.2017.10.056","article-title":"Lovastatin inhibits visceral allodynia and increased colonic permeability induced by lipopolysaccharide or repeated water avoidance stress in rats","volume":"818","author":"Nozu","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neures.2026.105135_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1530\/JOE-18-0441","article-title":"Altered colonic sensory and barrier functions by CRF: roles of TLR4 and IL-1","volume":"239","author":"Nozu","year":"2018","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.neures.2026.105135_bib25","doi-asserted-by":"crossref","first-page":"19603","DOI":"10.1038\/s41598-019-56132-4","article-title":"Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome","volume":"9","author":"Nozu","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neures.2026.105135_bib26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejphar.2019.03.037","article-title":"Dehydroepiandrosterone sulfate improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome","volume":"852","author":"Nozu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neures.2026.105135_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13819","article-title":"Losartan improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome","author":"Nozu","year":"2020","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.neures.2026.105135_bib28","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/0016-5085(94)90833-8","article-title":"Intracisternal injection of apolipoprotein A-IV inhibits gastric secretion in pylorus-ligated conscious rats","volume":"107","author":"Okumura","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neures.2026.105135_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2022.113914","article-title":"Oxytocin acts centrally in the brain to improve leaky gut through the vagus nerve and a cannabinoid signaling in rats","volume":"254","author":"Okumura","year":"2022","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neures.2026.105135_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134592","article-title":"Brain orexin improves intestinal barrier function via the vagal cholinergic pathway","volume":"714","author":"Okumura","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neures.2026.105135_bib31","doi-asserted-by":"crossref","first-page":"C1174","DOI":"10.1152\/ajpcell.00450.2011","article-title":"Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences","volume":"302","author":"Sabolic","year":"2012","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"10.1016\/j.neures.2026.105135_bib32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.neures.2026.105135_bib33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1749-6632.1990.tb16163.x","article-title":"Brain regulation of gastric acid secretion by peptides","volume":"597","author":"Tach\u00e9","year":"1990","journal-title":"Sites Mech. Action. Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.neures.2026.105135_bib34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S2213-8587(13)70050-0","article-title":"SGLT inhibitors in management of diabetes","volume":"1","author":"Tahrani","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.neures.2026.105135_bib35","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1006\/bbrc.1998.9994","article-title":"Stimulation of gastric acid secretion by centrally administered orexin-A in conscious rats","volume":"254","author":"Takahashi","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neures.2026.105135_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-002104","article-title":"Central administration of sodium-glucose cotransporter-2 inhibitors increases food intake involving adenosine monophosphate-activated protein kinase phosphorylation in the lateral hypothalamus in healthy rats","volume":"9","author":"Takeda","year":"2021","journal-title":"BMJ Open. Diabetes Res. Care"},{"key":"10.1016\/j.neures.2026.105135_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001308","article-title":"Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity","volume":"2","author":"Ukena","year":"2007","journal-title":"PLoS. One"},{"key":"10.1016\/j.neures.2026.105135_bib38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1681\/ASN.2010030246","article-title":"SGLT2 mediates glucose reabsorption in the early proximal tubule","volume":"22","author":"Vallon","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.neures.2026.105135_bib39","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00424-014-1619-7","article-title":"Localizations of Na(+)-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart","volume":"467","author":"Vrhovac","year":"2015","journal-title":"Pflug. Arch."},{"key":"10.1016\/j.neures.2026.105135_bib40","first-page":"317","article-title":"Altered Expression of D1 and D2 Dopamine Receptors in Vagal Neurons Innervating the Gastric Muscularis Externa in a Parkinson's Disease Rat Model","volume":"6","author":"Wang","year":"2016","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.neures.2026.105135_bib41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neures.2026.105135_bib42","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.34067\/KID.0002772021","article-title":"SGLT2 Inhibitors: Physiology and Pharmacology","volume":"2","author":"Wright","year":"2021","journal-title":"Kidney360"},{"key":"10.1016\/j.neures.2026.105135_bib43","doi-asserted-by":"crossref","first-page":"C1277","DOI":"10.1152\/ajpcell.00296.2010","article-title":"Functional expression of SGLTs in rat brain","volume":"299","author":"Yu","year":"2010","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"10.1016\/j.neures.2026.105135_bib44","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."}],"container-title":["Neuroscience Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010226001227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010226001227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:32:52Z","timestamp":1794346372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168010226001227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":44,"alternative-id":["S0168010226001227"],"URL":"https:\/\/doi.org\/10.1016\/j.neures.2026.105135","relation":{},"ISSN":["0168-0102"],"issn-type":[{"value":"0168-0102","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Centrally administered SGLT2 inhibitor improves gut barrier function through the brain orexin, AMPK, dopamine D2 signaling and the vagal pathway in rats","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neures.2026.105135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105135"}}